Tyra Biosciences, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| MORE ROBERT J | — | Sale | 10,000 | $25.00 | $250,000 | 3,823,425 | Dec 19, 2025 |
| Bensen Daniel | Chief Discovery Officer | Sale | 8,000 | $22.64 | $181,120 | 162,981 | Dec 12, 2025 |
| MORE ROBERT J | — | Sale | 246,871 | $20.25 | $4,999,138 | 3,833,425 | Nov 21, 2025 |
| Bensen Daniel | Chief Operating Officer | Sale | 75,633 | $16.07 | $1,215,422 | 220,937 | Nov 19, 2025 |
| Bensen Daniel | Chief Operating Officer | Sale | 1,111 | $16.00 | $17,776 | 426,870 | Nov 17, 2025 |
| Fuhrman Alan | Chief Financial Officer | Award / Grant | 701 | $9.13 | $6,400 | 14,788 | Sep 15, 2025 |
| KAPLAN GILLA | — | Sale | 10 | $10.35 | $104 | 37,799 | Jun 18, 2025 |
| KAPLAN GILLA | — | Sale | 6,814 | $10.38 | $70,729 | 37,809 | Jun 13, 2025 |
| RA CAPITAL MANAGEMENT, L.P. | — | Purchase | 120,167 | $10.20 | $1,225,703 | 10,247,478 | Jun 12, 2025 |
| RA Capital Healthcare Fund LP | — | Purchase | 186,850 | $10.19 | $1,904,002 | 10,096,004 | Jun 9, 2025 |
| Kolchinsky Peter | — | Purchase | 213,334 | $10.04 | $2,141,873 | 9,909,154 | Jun 4, 2025 |
| Harris Todd | President and CEO | Award / Grant | 1,241 | $9.78 | $12,137 | 1,357,168 | Mar 14, 2025 |
| Fuhrman Alan | Chief Financial Officer | Award / Grant | 1,238 | $9.78 | $12,108 | 14,087 | Mar 14, 2025 |
| Kjellson Nina S | — | Sale | 3,511 | $13.76 | $48,311 | 443,885 | Feb 5, 2025 |
| Kjellson Nina S | — | Sale | 4,825 | $16.26 | $78,455 | 3,702,595 | Jan 23, 2025 |
| Kjellson Nina S | — | Sale | 12,808 | $16.40 | $210,051 | 3,711,413 | Jan 16, 2025 |
| Kjellson Nina S | — | Sale | 566 | $16.84 | $9,531 | 448,692 | Nov 25, 2024 |
| RA Capital Healthcare Fund LP | — | Purchase | 1,220,681 | $16.25 | $19,836,066 | 8,697,956 | Nov 8, 2024 |
| Kjellson Nina S | — | Sale | 5,635 | $17.18 | $96,809 | 451,629 | Nov 6, 2024 |
| Kjellson Nina S | — | Sale | 116 | $17.01 | $1,973 | 458,390 | Nov 4, 2024 |
| Kjellson Nina S | — | Sale | 9,889 | $16.17 | $159,905 | 3,926,706 | Oct 31, 2024 |
| Fuhrman Alan | Chief Financial Officer | Purchase | 9,500 | $16.00 | $152,000 | 12,849 | Oct 30, 2024 |
| Harris Todd | President and CEO | Sale | 5,896 | $27.32 | $161,079 | 1,369,115 | Oct 21, 2024 |
| Boxer Capital Management, LLC | — | Disposition | 2,000,000 | — | — | 4,448,359 | Oct 18, 2024 |
| Kolchinsky Peter | — | Other | 1,000,000 | — | — | 7,477,275 | Oct 18, 2024 |
| Harris Todd | President and CEO | Sale | 24,475 | $26.23 | $641,979 | 1,437,963 | Oct 16, 2024 |
| Harris Todd | President and CEO | Sale | 500 | $24.00 | $12,000 | 1,477,373 | Sep 30, 2024 |
| Harris Todd | President and CEO | Sale | 10,092 | $24.13 | $243,520 | 1,479,528 | Sep 25, 2024 |
| Harris Todd | President and CEO | Sale | 3,500 | $24.00 | $84,000 | 1,502,427 | Sep 20, 2024 |
| Harris Todd | President and CEO | Award / Grant | 1,350 | $6.58 | $8,883 | 1,505,927 | Sep 13, 2024 |
| Fuhrman Alan | Chief Financial Officer | Award / Grant | 954 | $12.48 | $11,906 | 3,349 | Sep 13, 2024 |
| KAPLAN GILLA | — | Option Exercise | 61,392 | $0.61 | $37,449 | 89,623 | Jun 13, 2024 |
| Bensen Daniel | Chief Operating Officer | Sale | 3,502 | $20.00 | $70,040 | 427,981 | Jun 7, 2024 |
| Fuhrman Alan | Chief Financial Officer | Award / Grant | 932 | $12.48 | $11,631 | 2,395 | Mar 15, 2024 |
| Tada Hiroomi | Chief Medical Officer | Award / Grant | 1,968 | $6.58 | $12,949 | 86,435 | Mar 15, 2024 |
| Harris Todd | President and CEO | Award / Grant | 1,880 | $6.58 | $12,370 | 1,504,577 | Mar 15, 2024 |
| Bensen Daniel | Chief Operating Officer | Sale | 200 | $20.00 | $4,000 | 431,683 | Mar 11, 2024 |
| Bensen Daniel | Chief Operating Officer | Sale | 68 | $20.00 | $1,360 | 431,883 | Mar 6, 2024 |
| Bensen Daniel | Chief Operating Officer | Sale | 5,063 | $20.08 | $101,665 | 434,873 | Mar 5, 2024 |
| Bensen Daniel | Chief Operating Officer | Sale | 5,849 | $20.13 | $117,740 | 444,886 | Feb 29, 2024 |
| Bensen Daniel | Chief Operating Officer | Sale | 1,501 | $20.00 | $30,020 | 451,480 | Feb 12, 2024 |
| Bensen Daniel | Chief Operating Officer | Sale | 9,587 | $18.09 | $173,429 | 452,981 | Feb 7, 2024 |
| Shah Rajeev M. | — | Award / Grant | 3,180,155 | $13.01 | $41,373,817 | 8,477,275 | Feb 6, 2024 |
| Boxer Capital, LLC | — | Award / Grant | 63,412 | $13.01 | $824,990 | 85,939 | Feb 6, 2024 |
| Bensen Daniel | Chief Operating Officer | Option Exercise | 25,393 | $0.61 | $15,490 | 553,374 | Feb 6, 2024 |
| Harris Todd | President and CEO | Sale | 7,187 | $17.04 | $122,466 | 1,516,514 | Feb 5, 2024 |
| Tada Hiroomi | Chief Medical Officer | Award / Grant | 1,337 | $6.58 | $8,797 | 84,467 | Sep 15, 2023 |
| Harris Todd | President and CEO | Award / Grant | 1,421 | $6.58 | $9,350 | 1,602,697 | Sep 15, 2023 |
| Fuhrman Alan | Chief Financial Officer | Award / Grant | 1,463 | $12.50 | $18,288 | 1,463 | Sep 15, 2023 |
| Bensen Daniel | Chief Operating Officer | Sale | 3,900 | $16.01 | $62,439 | 527,981 | Jul 19, 2023 |